: iStockAnalyst.com Symbols Feed

In Search of Healthcare Diamonds In The Rough

Mon, 12 Jan 2009 04:52:00 GMT

While we are not even halfway through January, the healthcare sector is already active with deal-making, ranging from the rumored $95 buyout of biotech giant Genetech (DNA) by Roche (RHHBY) to Endo's (ENDP) purchase of small-cap, specialty pharma Indevus (IDEV) to Sequenom's (SQNM) $41M offer for emerging diagnostic company EXACT Sciences (EXAS) – which was promptly rebuffed by EXACT's board after the market close on Monday on the promise of a better deal in the works for shareholders. Larger bio-pharma and diagnostic companies are opportunistically looking to expand their product offerings, pipeline prospects, patent portfolios, and drug discovery technology platforms given the huge declines in the stock prices of small/micro-cap stocks in the healthcare sector. With that in mind, I sorted through the ETF Innovators indexes for a list of a dozen[More...]

Weekly Mergers and Acquisitions Report - 01-06-2009

Wed, 07 Jan 2009 13:27:05 GMT

M&A report for $Wavecom (WVCM) - Sierra Wireless (SWIR) , $Indevus Pharmaceuticals (IDEV) - Endo Pharmaceuticals (ENDP), $Datascope Corp. (DSCP) - Getinge AB, Embarq Corporation (EQ) - CenturyTel, Inc. (CTL), $Mentor Corp (MNT) - Johnson Johnson (JNJ[More...]

Sykes Says: Some Suppressive SEC Short Selling Scrap Stocks Suckas!

Thu, 02 Oct 2008 16:15:00 GMT

Not much for me to watch today considering spamers are all but out of business/effectiveness right now and the Sec just voted to extend the ban on short selling businesses run by incompetent people aka financials…I usually stay away from from financials anyway, but when there are absurd moves like TMA and BBX, my mouth waters and all I can do is spit right at Big Brother SEC himself. Here are today’s scraps: EFJI won real contracts, another IDEV-type play, I respect meaningful order wins, I don’t short unless the action is really ridiculous, which isn’t the case here…yet. RZ is the best looking out of all these mediocre/ugly plays, like the last girl at the bar right before closing time, I’m not giving in, she’s taken quite a few shorts home with her and they complained of burning and squeezing over the next few days…replace burning with squeezing and that’s what could happen here. But[More...]

Eight White Hot Stocks You Should Know About

Mon, 29 Sep 2008 14:53:00 GMT

This was sent premarket to all TIMalert subscribers:Nothing truly great to start the week off, I’m still in the Florida Keys and I’m gonna go skydiving today…don’t worry, I’ve already been twice, it’s a piece of cake…IDEV got positive drug news and a hunk of money form a major pharmaceutical, I’m not gonna be so quick to short such a power packed deal, of course it could reverse, but I prefer shorting hype and manipulation to real deals like this. That said, if it goes up and squeezes some shorts enough, it’s a potential play.LSCG is a two-day spiker, chart is decent for a reversal but there is a shareholder meeting this Thursday so it’s not ideal (news could be announced).CYPB has the right longterm downtrending chart, spike off the bottom, but a history of taking weeks to reverse after[More...]

Indevus Pharmaceuticals, Inc. : The Subway Stock Trader Pick of the Day

Fri, 26 Sep 2008 16:25:00 GMT

This morning we are looking at Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) for a trade. IDEV is up nice on news this morning in a bad tape:[More...]

NASDAQ Technical Picture - Narrow Range Day

Wed, 21 May 2008 05:55:59 GMT

: iStockAnalyst.com Symbols Feed

In Search of Healthcare Diamonds In The Rough

Weekly Mergers and Acquisitions Report - 01-06-2009

Sykes Says: Some Suppressive SEC Short Selling Scrap Stocks Suckas!

Eight White Hot Stocks You Should Know About

Indevus Pharmaceuticals, Inc. : The Subway Stock Trader Pick of the Day

NASDAQ Technical Picture - Narrow Range Day

Fed cut rally- Day Two

FDA Accepts Complete Response Submission to Endo’s NDA for NEBIDO

Endo Pharmaceuticals Completes Indevus Tender Offer

Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals

Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

Burns & Levinson Guides Indevus Through Significant Pharmaceutical Transaction

Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals

Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results

Zacks Analyst Blog Highlights: Sohu.Com, Inc., Priceline.Com, Dollar Financial Corp., Indevus Pharmaceuticals and Endo Pharmaceuticals.

BenchmarkJournal.Com (Complimentary) Analyst Review for IDEV, AMED, ENDP and CIEN

Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals

Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals

Form 4 Endo Pharmaceuticals For: Mar 23 Filed by: ENDO PHARMACEUTICALS HOLDINGS INC (10K)

Form 4 INDEVUS PHARMACEUTICALS For: Mar 20 Filed by: ENDO PHARMACEUTICALS HOLDINGS INC (10K)

Form 4 INDEVUS PHARMACEUTICALS For: Mar 05 Filed by: BTB Purchaser Inc. (10K)

Form 4/A INDEVUS PHARMACEUTICALS For: Feb 24 Filed by: BTB Purchaser Inc. (10K)

Form 4 INDEVUS PHARMACEUTICALS For: Feb 25 Filed by: PERCEPTIVE ADVISORS LLC (10K)

Form 4 INDEVUS PHARMACEUTICALS For: Feb 24 Filed by: BTB Purchaser Inc. (10K)

Form 3/A INDEVUS PHARMACEUTICALS For: Feb 23 Filed by: BTB Purchaser Inc. (10K)

Form 3 Wysenski Nancy For: Feb 23 (10K)

Form 3 Holveck David For: Feb 23 (10K)

Form 3 Gergel Ivan P. For: Feb 23 (10K)